Random42 were one of the pioneers of medical animation, as one of the first companies to develop animated sequences used to demonstrate the mechanism of action (MOA) of a drug or disease area. Since we were established in 1992, we have become the largest company within this space, whilst improving quality year on year, demonstrated by the fact that we have won over 250 awards.
Random42 is a world leader in providing scientific Virtual Reality (VR) and Augmented Reality (AR). Our R&D team have diverse backgrounds, with Interaction Designers that are experienced in motion and interactive design installations. They are the first to develop new tools and technologies and are at the forefront of developing Random42’s pipeline for new design technologies.
We believe that our experience and knowledge in this space is unparalleled. We have gained vast experience across almost all therapeutic areas through the digital assets we have created for hundreds of global pharmaceutical products. We have also worked extensively in consumer health, medical devices and diagnostic tests, and animal health. We have also collaborated with the film industry to develop various scientific documentaries.
We continue to exist as leaders in innovative new technologies, and our offering of new tech has expanded immensely. With the advent of tablets, large touchscreens, virtual reality headsets and fast broadband streaming, we are able to elevate our visual storytelling to a new level.
‘‘I have been to a lot of conferences and I have seen a lot of videos both from competitors and internally – in my eyes it is night and day. The quality Random42 have is not one step ahead, it is far ahead compared to what I have seen before.‘‘
Scientific Affairs, Amgen
‘‘We were keen to try a new provider. We wanted to use newer technology, and we realized from the comments from the web and material on their website, that they are good. Their strength is in the visuals and the technology.‘‘
Global Brand Manager, BIAL
‘‘Random42 are prepared to push innovation to the latest tech that’s available and give it a go – that’s something that I’m attracted to.‘‘
Head of Commercial Operations, Novartis